stockrowSotera Health Company
SHC Healthcare Diagnostics & Research
Sotera Health Company’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 5.74% from fiscal 2024.
- Revenue
- +4.36%
- EPS
- +20.1%
- Free cash flow
- +65.0%
- Total debt
- +0.14%
Quarter to September 2026, against a year earlier
Follow SHC
Alert me
Sotera Health Company (SHC) Revenue
Sotera Health Company's revenue for fiscal 2025 was $1.2B, up 5.74% from $1.1B in fiscal 2024. Over the twelve months to 30 September 2026 it was $1.2B. Over the past ten years it has ranged from $746.1M (fiscal 2018) to $1.2B (fiscal 2025) — the current reading is the highest in ten years. Revenue has risen for 7 consecutive fiscal years. Sotera Health Company ranks 19th of 47 Diagnostics & Research companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $1.2B | 5.74% |
| FY2024 | $1.1B | 4.88% |
| FY2023 | $1.0B | 4.54% |
| FY2022 | $1.0B | 7.75% |
| FY2021 | $931.5M | 13.85% |
| FY2020 | $818.2M | 5.12% |
| FY2019 | $778.3M | 4.31% |
| FY2018 | $746.1M | — |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Sep 2026 | $324.9M | 1.09% |
| Jun 2026 | $321.4M | 14.76% |
| Mar 2026 | $280.0M | (7.71%) |
| Dec 2025 | $303.4M | (2.53%) |
| 24 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| RDNT RadNet, Inc. compare | $2.3B |
| QGEN QIAGEN N.V. compare | $2.1B |
| SHC Sotera Health Company | $1.2B |
| NEO NeoGenomics, Inc. compare | $787.8M |
| VCYT Veracyte, Inc. compare | $581.8M |
| CDNA CareDx, Inc. compare | $497.4M |
| BLLN BillionToOne, Inc. compare | $436.9M |
| ADPT Adaptive Biotechnologies Corporation compare | $298.0M |
| GRAL GRAIL, Inc. compare | $166.6M |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on SHC
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement